Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,070
Closed -$341K 424
2022
Q4
$341K Hold
3,070
0.06% 148
2022
Q3
$264K Sell
3,070
-183
-6% -$16.3K 0.05% 158
2022
Q2
$297K Sell
3,253
-116
-3% -$10.3K 0.05% 157
2022
Q1
$276K Buy
3,369
+88
+3% +$6.94K 0.04% 180
2021
Q4
$251K Buy
3,281
+1,188
+57% +$94.6K 0.04% 201
2021
Q3
$157K Sell
2,093
-1,014
-33% -$77.1K 0.03% 223
2021
Q2
$242K Sell
3,107
-149
-5% -$11.1K 0.04% 165
2021
Q1
$240K Buy
+3,256
New +$240K 0.05% 164

Other funds holding MRK

Sierra Capital's MRK Position: Q1 2023 in Review

Sierra Capital sold out of Merck (MRK) in Q1 2023, closing a stake of 3,070 shares — an estimated $341K sold.

Sierra Capital first reported a position in MRK in Q1 2021 and held it in 8 quarters. The position peaked at $341K in Q4 2022. 3,179 funds tracked by Wall St. Rank hold MRK as of Q1 2023.

  • Sierra Capital reported no remaining Merck position as of Q1 2023 after selling out during the quarter.
  • Sierra Capital sold 3,070 Merck shares in Q1 2023, an estimated $341K.
  • Sierra Capital first reported a position in Merck in Q1 2021 and held it in 8 quarters.
  • Sierra Capital's Merck position peaked at $341K in Q4 2022.
  • 3,179 funds tracked by Wall St. Rank held Merck as of Q1 2023.

Based on Sierra Capital's 13F filing for Q1 2023, filed 1 May 2023.